Scientific Advisory Board

Scientific Advisory Board

Aspect Imaging’s Scientific Advisory Board is comprised of world-class researchers and imaging experts who serve as an advisory group to the company regarding its research and development projects.

Robert Lenkinski, Ph.D

Vice-Chair, Research, Department of Radiology
Department of Radiology
Professor of Radiology
Charles A. and Elizabeth Ann Sanders Chair in Translational Research
Jan and Bob Pickens Distinguished Professorship in Medical Science
UT Southwestern
Dallas, Texas

Dr. Lenkinski is Vice-Chair, Research and Professor of Radiology at UT Southwestern in Dallas. Previously, he was a Professor of Radiology at Harvard Medical School, a Vice-Chairman and Director of Radiology Research at Beth Israel Deaconess Medical Center, and Co-Director,Longwood Small Animal Imaging Facility. One of his major research interests is the clinical applications of in vivo Magnetic Resonance spectroscopy. Dr Lenkinski is also developing in vivo multinuclear MR imaging methods. A more recent area of interest has been molecular imaging. He received his Ph.D in Chemistry from the University of Houston. He has authored many articles in peer-reviewed journals and has been awarded several patents.

View Dr. Lenkinski’s publications on:

 Allan G. Johnson, Ph.D

Director, Center for In Vivo Microscopy
Charles E. Putman Distinguished Professor of Radiology,
Professor of Biomedical Engineering and Physics
Duke University, NC

Dr. Johnson is Director of the Center for In Vivo Microscopy, an NIH/NCRR National Biomedical Technology Resource Center. He received his PhD in Physics from Duke University in 1974 in electron spin resonance under Professor Walter Gordy. He was responsible for installing the first CT system at Duke in 1974 (the 2nd CT system in the US). From 1981-83 he worked with GE to install the world’s first high field (1.5T) clinical MRI system. He holds appointments in Radiology, Physics, and Biomedical Engineering as the Charles E. Putman University Professor. He is co-author on more than 250 peer-reviewed papers. Dr. Johnson is the principal investigator of the Duke Molecular Imaging Center supported by the National Cancer Institute to develop new imaging strategies for the detection and characterization of cancer and the application of those techniques in preclinical studies. He is also a principal investigator in the Mouse Biomedical Informatics Research Network (MBIRN), a multi-institutional collaboration that integrates studies in the mouse from millimeter to submicron resolution. Dr. Johnson’s personal research is in magnetic resonance histology (MRH), the application of MR microscopy to the study of tissue architecture. The use of MRH for morphologic phenotyping in the mouse was first suggested by Dr. Johnson and his colleagues in 1993. More recently MRH has been extended to 21 microns in the mouse brain for high throughput phenotyping. Dr. Johnson and his team are currently focused on extending the technology to achieve spatial resolution approaching the theoretical limit of ~10 microns.

View Dr. Johnson’s publications on:

Peter Bendel, Ph.D

Chief Technology Officer
Aspect Imaging
Shoham, Israel

In February of 2012, Dr. Bendel joined Aspect Imaging as Chief Technology Officer. Previously, Dr. Bendel was a Senior Staff Researcher at the Weizmann Institute of Science, where he was the Director of the NMR and MRI facilities in the Department of Chemical Research Support. He has over 30 years’ of experience in the field of MRI, including having worked as R & D Physicist at Elscint, as a Visiting Scientist at the University of Tennessee Medical Center, and in the Corporate Research Laboratory of ExxonMobil.

View Dr. Bendel’s publications on:

Prof. Gomori Moshe, Ph.D

Head of MRI and Neuroradiology Unit, Dept. of Medical Imaging,
Hadassah Medical Center, Jerusalem, Israel.
Professor of Radiology, the Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Adjunct Associate Professor of Radiology at the University of Pennsylvania, School of Medicine 

In August 2018, Prof. Gomori joined Aspect Imaging’s Advisory Board. Professor Gomori is Head of MRI and Neuroradiology Unit, Dept. of Medical Imaging, Hadassah Medical Center, Jerusalem, Israel. Professor Gomori graduated from MIT and received his MD from Harvard University.
Following a residency at the Harvard Medical School from 1977-1980, Professor Gomori joined the Department of Diagnostic Radiology at Hadassah as Head of Neuroradiology in 1981 and was named Head of Magnetic Resonance in 1987. He is a Professor of Radiology at the Hebrew University Faculty of Medicine and holds a joint appointment as Adjunct Associate Professor of Radiology at the University of Pennsylvania School of Medicine, where he completed a Neuroradiology Fellowship in 1984-85.
Professor Gomori has published and lectured widely in the fields of neuroradiology and MRI, and serves as a reviewer of top international journals in these fields.

View Prof. Gomori’s publications on:

 Michael J. McCarthy, Ph.D.

Professor and Chair Department of Food Science and Technology
Professor of Engineering Department of Biological and Agricultural Engineering
University of California Davis
Davis, California, USA
Member and Principal Investigator for the Center for Process Analysis and Control
University of Washington, Seattle, WA, USA

McCarthy’s research program is focused on industrial applications of magnetic resonance imaging and time domain nuclear magnetic resonance. He is a pioneer in the use of MRI to understand and quantify transport phenomena during food processing and to develop MRI for the measurement of fluid rheology and mixing. McCarthy has worked extensively with industry and NGO’s during his academic career including a sabbatical with Nestlé in 1996-1997 and a sabbatical with Aspect Imaging/Paramount Citrus Association in 2007.  He received his Ph.D. in Chemical Engineering from the University of California Berkeley. McCarthy has co-authored over 200 peer-reviewed journal articles and has been awarded four patents.


Contact Us

  • This field is for validation purposes and should be left unchanged.

Contact us

Font Resize